|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.890 USD | +4.21% |
|
+3.78% | +47.17% |
| Mar. 03 | Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM | |
| Feb. 26 | Health Care Down Amid Mixed Earnings -- Health Care Roundup | DJ |
Company Valuation: Novavax, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,817 | 883.9 | 570.2 | 1,288 | 1,092 | 1,611 | - | - |
| Change | - | -91.83% | -35.49% | 125.87% | -15.21% | 47.57% | - | - |
| Enterprise Value (EV) 1 | 9,756 | -228.1 | 169.7 | 534.5 | 1,092 | 1,830 | 1,915 | 1,611 |
| Change | - | -102.34% | 174.39% | 214.93% | 104.32% | 67.62% | 4.6% | -15.84% |
| P/E ratio | -6.1x | -1.22x | -0.89x | -6.54x | 2.6x | -32x | -33.2x | 24.7x |
| PBR | -30.9x | -1.38x | -0.93x | -2.07x | - | -2.82x | -2.7x | - |
| PEG | - | 0x | 0x | 0.1x | -0x | 0x | 9.36x | -0x |
| Capitalization / Revenue | 9.44x | 0.45x | 0.58x | 1.89x | 0.97x | 4.2x | 6.57x | 4.75x |
| EV / Revenue | 8.51x | -0.12x | 0.17x | 0.78x | 0.97x | 4.77x | 7.8x | 4.75x |
| EV / EBITDA | - | 0.37x | -0.32x | -2.67x | - | -75.7x | -38.9x | -35.5x |
| EV / EBIT | -5.78x | 0.35x | -0.3x | -2.15x | 1.98x | -34.5x | -41.4x | 28.1x |
| EV / FCF | 36.8x | 0.45x | -0.22x | -5.33x | - | 15.5x | -19.3x | 5.95x |
| FCF Yield | 2.72% | 221% | -452% | -18.8% | - | 6.45% | -5.17% | 16.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.44 | -8.42 | -5.41 | -1.23 | 2.58 | -0.3092 | -0.2983 | 0.4 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,146 | 1,982 | 983.7 | 682.2 | 1,123 | 383.5 | 245.4 | 338.9 |
| EBITDA 1 | - | -615.7 | -525.3 | -200.4 | - | -24.18 | -49.22 | -45.37 |
| EBIT 1 | -1,687 | -644.7 | -566.5 | -248.9 | 550.6 | -53.1 | -46.24 | 57.33 |
| Net income 1 | -1,744 | -657.9 | -545.1 | -187.5 | 440.3 | -49.28 | -49.56 | 68.93 |
| Net Debt 1 | -1,061 | -1,112 | -400.5 | -753.4 | - | 219 | 303.2 | - |
| Reference price 2 | 143.070 | 10.280 | 4.800 | 8.040 | 6.720 | 9.890 | 9.890 | 9.890 |
| Nbr of stocks (in thousands) | 75,608 | 85,979 | 118,790 | 160,185 | 162,499 | 162,936 | - | - |
| Announcement Date | 2/28/22 | 2/28/23 | 2/28/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -31.98x | 4.77x | -75.7x | -.--% | 1.61B | |
| 36.78x | 5.34x | 17.88x | 0.93% | 47.3B | |
| 52.42x | 10.75x | 30.08x | 0.36% | 29.54B | |
| 53.97x | 4.64x | 32.05x | -.--% | 33.17B | |
| 21.57x | 2.49x | 10.73x | -.--% | 29.86B | |
| -13.21x | 327.03x | -11.23x | -.--% | 20.05B | |
| 45.17x | 8.68x | 30.55x | -.--% | 14.82B | |
| 21.85x | 1.99x | 8.71x | 1.13% | 13.72B | |
| 27.25x | 4.35x | 19.77x | -.--% | 13.22B | |
| -19.65x | 15.36x | -21.41x | -.--% | 13.12B | |
| Average | 19.42x | 38.54x | 4.14x | 0.24% | 21.64B | |
| Weighted average by Cap. | 29.93x | 35.94x | 15.36x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- NVAX Stock
- Valuation Novavax, Inc.
Select your edition
All financial news and data tailored to specific country editions
